REKOM BIOTECH APPEARS IN IDEAL AS ONE OF THE COMPANIES FROM GRANADA AGAINST COVID-19

4/6/2020

On 6th April, 2020 , Rekom Biotech appeared in the newspaper IDEAL, where were shown the different projects that exist in Granada (Spain) about COVID-19. One of them is the project of Rekom Biotech, which consists of designing and producing recombinant antigens focused on the spike protein of the virus, as well as a multi-epitope chimera which improve its antigenic capacity. They are being expressed in bacteria and in yeast. "This last expression system could give an antigen with better antigenic characteristics, due to its ability to mimic the native folding of the produced heterologous protein. This would lead to a better biomarker and, consequently, a faster and more accurate diagnostic. We are working on improving the antigenic and physicochemical characteristics of the antigen, so that we can improve its versatility and can be used in the different rapid in vitro diagnostic platforms on the market", said Dr. Ana Camacho, CEO of Rekom Biotech.

If you want to keep up to date with all our latest advances, do not hesitate to subscribe to our Newsletter.